Stryker beats by $0.03, beats on revs; guides Q1 EPS in-line; guides FY19 EPS above consensus (161.01 -0.98)
- Reports Q4 (Dec) earnings of $2.18 per share, excluding non-recurring items, $0.03 better than the S&P Capital IQ Consensus of $2.15 and at high end of prior guidance of $2.13-2.18; revenues rose 9.4% year/year to $3.80 bln vs the $3.73 bln S&P Capital IQ Consensus.
- Co issues in-line guidance for Q1, sees EPS of $1.80-1.85, excluding non-recurring items, vs. $1.84 S&P Capital IQ Consensus.
- Co issues upside guidance for FY19, sees EPS of $8.00-8.20, excluding non-recurring items, vs. $8.01 S&P Capital IQ Consensus. Co expects organic sales growth of +6.5-7.5%. We note this is not comparable to consensus